Halbert Hargrove Global Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,875
Closed -$214K 175
2022
Q4
$214K Buy
+2,875
New +$196K 0.02% 149
2022
Q2
Sell
-3,750
Closed -$277K 160
2022
Q1
$277K Hold
3,750
0.02% 126
2021
Q4
$271K Hold
3,750
0.02% 128
2021
Q3
$287K Hold
3,750
0.02% 112
2021
Q2
$291K Hold
3,750
0.02% 116
2021
Q1
$231K Hold
3,750
0.02% 116
2020
Q4
$245K Buy
+3,750
New +$216K 0.02% 96

Other funds holding GMED

Halbert Hargrove Global Advisors's GMED Position: Q1 2023 in Review

Halbert Hargrove Global Advisors sold out of Globus Medical (GMED) in Q1 2023, closing a stake of 2,875 shares — an estimated $214K sold.

Halbert Hargrove Global Advisors first reported a position in GMED in Q4 2020 and held it in 7 quarters. The position peaked at $291K in Q2 2021. 390 funds tracked by Wall St. Rank hold GMED as of Q1 2023.

  • Halbert Hargrove Global Advisors reported no remaining Globus Medical position as of Q1 2023 after selling out during the quarter.
  • Halbert Hargrove Global Advisors sold 2,875 Globus Medical shares in Q1 2023, an estimated $214K.
  • Halbert Hargrove Global Advisors first reported a position in Globus Medical in Q4 2020 and held it in 7 quarters.
  • Halbert Hargrove Global Advisors's Globus Medical position peaked at $291K in Q2 2021.
  • 390 funds tracked by Wall St. Rank held Globus Medical as of Q1 2023.

Based on Halbert Hargrove Global Advisors's 13F filing for Q1 2023, filed 25 Apr 2023.